Skip to main content
SpringerLink
Log in

Cyclosporin a treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In a pilot study 23 children with nephrotic syndrome were treated with cyclosporin A (Cs) for 6–45 months. 8 children suffered from steroid dependent minimal change nephrotic syndrome (MCNS) and had experienced at least one course with cytotoxic drugs, but had relapsed thereafter. 2 children had diabetes mellitus type I with nephrotic syndrome and 13 children had steroid resistant focal segmental glomerulosclerosis (FSGS). Cs was started with 100 mg/m2/day in two doses and increased stepwise to obtain a Cs whole blood trough level of 200–400 ng/ml. In steroid dependent MCNS treatment with Cs reduced relapse rate significantly, and prednisone therapy could be stopped completely. After discontinuation of Cs, relapses reoccurred as frequently as before. Renal function remained unimpaired despite repeated Cs treatment courses up to 38 months. In cases of nephrotic syndrome with diabetes type I Cs treatment led to complete remission without changing the insulin requirement. However, after discontinuation of Cs relapses reoccurred. In steroid resistant FSGS 6 children benefited from Cs treatment: 4 went into complete remission, 2 into partial remission. The 2 children with complete remission relapsed but remained Cs responsive. The remaining 7 children with FSGS did not respond to Cs but continued the course of their disease, with two patients rapidly progressing to terminal renal failure. Side-effects of Cs treatment were mild. It is concluded that Cs is an effective agent in steroid dependent MCNS and can be used as an alternative drug in specific cases like steroid toxicity or diabetes mellitus. In steroid resistant FSGS a trial with Cs seems to be warranted since some cases do respond favorably. To avoid nephrotoxicity treatment with Cs should always be monitored closely by determination of blood levels and renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MCNS:

minimal change nephrotic syndrome

FSGS:

focal segmental glomerulosclerosis

Cs:

Cyclosporin A

References

  1. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1979) Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. Lancet I:401–403

    Google Scholar 

  2. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454

    Google Scholar 

  3. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight weeks with 12 weeks course. Arch Dis Child 62:1102–1106

    Google Scholar 

  4. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet I:380–383

    Google Scholar 

  5. Arbus GS, Poucell S, Bacheyie GS, Baumal R (1982) Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 101:40–45

    Google Scholar 

  6. Barnett HL, Schoeneman M, Bernstein J, Edelman CM (1978) Minimal change nephrotic syndrome. In: Edelmann CM (ed) Pediatric Kidney Disease. Little Brown, Boston, pp 695–711

    Google Scholar 

  7. Bennett WM, Norman DJ (1986) Action and toxicity of cyclosporine. Ann Rev Med 37:215–224

    Google Scholar 

  8. Borel JF, Ryffel B (1985) The mechanism of action of ciclosporin: a continuing puzzle. In: Schindler R (ed) Ciclosporin in Autoimmune Diseases. Springer, Berlin Heidelberg, pp 24–32

    Google Scholar 

  9. Brandis M, Burghard R, Leititis J, Zimmerhackl B, Hildebrandt F, Helmcher U (1987) Cyclosporine A for treatment in nephrotic syndrome. Pediatr Nephrol 1:C 42

    Google Scholar 

  10. Brodehl J, Ehrich JHH, Hoyer PF, Lee IJ, Oemar BS, Wonigeit K (1987) Cyclosporin A treatment of minimal change nephrotic syndrome and focal segmental glomerulosclerosis in children. Korean J Nephrology 6:26–33

    Google Scholar 

  11. Brodehl J, Hoyer PF (1985) Ciclosporine A treatment of idiopathic syndrome in children: minimal change disease and focal segmental glomerulosclerosis. In: Schindler R (ed) Ciclosporin in autoimmune diseases. Springer, Berlin Heidelberg, pp 329–333

    Google Scholar 

  12. Brodehl J, Krohn HP, Ehrich JHH (1982) The treatment of minimal change nephrotic syndrome (lipoidnephrosis): Cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN). Klin Pädiat 194:162–165

    Google Scholar 

  13. Cameron JS, Glassock RJ (1988) Natural history and outcome of the nephrotic syndrome. In: Cameron JS, Glassock RJ (eds) The nephrotic syndrome. Marcel Dekker, New York Basel, pp 999–1033

    Google Scholar 

  14. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218

    Google Scholar 

  15. Capodicasa G, Desanto NG, Nuzzi F, Giordano C (1986) Cyclosperin A in nephrotic syndrome of childhood — a 14 month experience. Intern J Pediatr Nephrol 7:69–72

    Google Scholar 

  16. Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges RA (1981) Radioimmuno assay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2:19–32

    Google Scholar 

  17. Dunnill MS (1984) Minimal change glomerulonephritis. In: Pathological basis of renal disease. Bailliere Tindall, London, pp 206–222

    Google Scholar 

  18. Feehally J, Beattle TJ, Brenchley PEC, Coupes BM, Houston IB, Mallick NP, Postlethwaite RJ (1984) Modulation of cellular immune function by cyclophosphamide in children with minimal change nephropathy. N Engl J Med 310:415–420

    Google Scholar 

  19. Fodor P, Saitua MT, Rodriguez E, Gonzalez B, Schlesinger L (1982) T-Cell dysfunction in minimal-change nephrotic syndrome of childhood. Am J Dis Child 136:713–717

    Google Scholar 

  20. Habib R, Churg J (1984) Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: individual entities or a spectrum of disease. In: Robinson RR (ed) Nephrology. Springer, Berlin Heidelberg New York, pp 634–644

    Google Scholar 

  21. Habib R, Gubler MC (1971) Les lesions glomerulaires focales des syndromes nephrotiques idiopathiques de l'enfant. Nephron 8:382–401

    Google Scholar 

  22. Habib R, Kleinknecht C, Royer P (1971) Le syndrome nephrotique primitif de l'enfant: classification et etude anatomo-clinique de 406 observations. Arch Franc Pediatr 28:277–319

    Google Scholar 

  23. Hoyer PF, Krull F, Brodehl J (1986) Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet II:335

    Google Scholar 

  24. Hoyer PF, Lee IJ, Oemar BS, Krohn HP, Offner G, Brodehl J (1988) Renal handling of uric acid under cyclosporin A treatment. Pediatr Nephrol 2:18–21

    Google Scholar 

  25. Hoyer PF, Offner G, Oemar BS, Brodehl J, Ringe B, Pichlmayr S (1988) Four years experience with cyclosporin A in pediatric kidney transplantation. Transplant Proceed 20 Suppl 3:274–279

    Google Scholar 

  26. International Study of Kidney Disease in Children (1974) Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2:423–427

    Google Scholar 

  27. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564

    Google Scholar 

  28. International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101:514–518

    Google Scholar 

  29. International Study of Kidney Disease in Children (1984) Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 year's observation. Pediatrics 73:497–501

    Google Scholar 

  30. Koskimies O, Vilska J, Rapola J, Hallmann N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544–548

    Google Scholar 

  31. Krull F, Hoyer PF, Offner G, Brodehl J (1988) Renal handling of magnesium in transplanted children under cyclosporin treatment. Eur J Pediatr (accepted)

  32. a Lagrue C, Laurent J, Belghiti D, Robeva R (1986) Cyclosporin and idiopathic nephrotic syndrome. Lancet II:692–693

    Google Scholar 

  33. Mathew TH (1988) Nephrotic syndrome in patients with transplanted kidneys. In: Cameron JS, Glassock RJ (ed) The nephrotic syndrome. Marcel Dekker, New York Basel, pp 805–847

    Google Scholar 

  34. Meyrier A (1987) Treatment with cyclosporin of patients with idiopathic nephrotic syndrome. Springer Semin Immunopathol 9:441–450

    Google Scholar 

  35. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC (1986) Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Brit Med J 292:789–792

    Google Scholar 

  36. Mihatsch MJ, Bach JF, Coovadia HM, Forre O, Moutsopoulos HM, Drosos AA, Siamopolous KC, Noel LH, Ramsaroop R, Hällgren R, Svenson K, Bohman SO (1988) Cyclsoporin-associated nephropathy in patients with autoimmune diseases. Klin Wochenschr 66:43–47

    Google Scholar 

  37. Moncrieff MW, White RH, Ogg CS, Cameron JS (1969) Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J I:666–671

    Google Scholar 

  38. Niaudet P, Habib R, Tete MJ, Hinglais N, Broyer M (1987) Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1:566–573

    Google Scholar 

  39. Peces R, Riera JR, Lopez Larrera C, Alvarez J (1987) Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child. Nephron 46:78–82

    Google Scholar 

  40. Shaloup RJ (1975) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet II:556–560

    Google Scholar 

  41. Shoeneman MJ, Bennett B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9:45–54

    Google Scholar 

  42. Siegel NJ, Gaudio KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M (1981) Steroid-dependent nephrotic syndrome in children: Histopathology and relapses after cyclophosphamide treatment. Kidney Intern 19:454–459

    Google Scholar 

  43. Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Intern 27:442–449

    Google Scholar 

  44. Taube D, Brown Z, Williams DG (1984) Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis. Clin Nephrol 22:176–182

    Google Scholar 

  45. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1987) Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J Pediatr 111:1056–1062

    Google Scholar 

  46. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Intern 33:729–734

    Google Scholar 

  47. Tejani A, Nicastri AD, Sen D, Chen CK, Phadke K, Adamson O, Butt KMH (1983) Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis. Nephron 35:225–231

    Google Scholar 

  48. Trompeter RS, Hicks J, Lloyd BW, White RHR, Cameron JS (1985) Long-term outcome for children with minimal change nephrotic syndrome. Lancet I:368–370

    Google Scholar 

  49. Von Graffenried B, Krupp P (1986) Side effects of cyclosporin (Sandimmun) in renal transplant recipients and in patients with autoimmune diseases. Transplant Proceed 18:876–883

    Google Scholar 

  50. Waldo FB, Kohaut EC (1987) Therapy of focal segmental glomerulosclerosis with cyclosporin. Pediatr Nephrol 1:180

    Google Scholar 

  51. Wiliams SA, Makker SP, Ingelfinger JR, Grupe WE (1980) Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929–933

    Google Scholar 

  52. Wish JB (1986) Immunologic effects of cyclosporine (1986) Transplant Proceed 18, Suppl 2:15–18

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kinderklinik Medizinische Hochschule, Hannover

    J. Brodehl, P. F. Hoyer & J. H. H. Ehrich

  2. Universitäts-Kinderklinik, Marburg

    M. Brandis, R. Burghard, R. B. Zimmerhackl & W. Klein

  3. Pathologisches Institut der Universität, Göttingen

    U. Helmchen

  4. Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule, Hannover

    K. Wonigeit

Authors
  1. J. Brodehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Brandis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Helmchen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. F. Hoyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Burghard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. H. H. Ehrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. B. Zimmerhackl
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. Wonigeit
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodehl, J., Brandis, M., Helmchen, U. et al. Cyclosporin a treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 66, 1126–1137 (1988). https://doi.org/10.1007/BF01727848

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01727848

Key words

Search

Navigation